.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Cerilliant
QuintilesIMS
Federal Trade Commission
Chinese Patent Office
Merck
Queensland Health
Accenture
Fish and Richardson
Dow

Generated: July 22, 2017

DrugPatentWatch Database Preview

Details for Patent: 7,157,554

« Back to Dashboard

Details for Patent: 7,157,554

Title:Glycopeptide carboxy-saccharide derivatives
Abstract: Disclosed are glycopeptide derivatives substituted at the C-terminus and/or the R-terminus with a substituent that comprises one or more saccharide groups and a carboxy group; and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.
Inventor(s): Linsell; Martin S. (San Mateo, CA), Fatheree; Paul R. (San Francisco, CA), Leadbetter; Michael R. (San Leandro, CA), Zhu; Yan (Foster City, CA), Judice; J. Kevin (El Granada, CA)
Assignee: Theravance, Inc. (South San Francisco, CA)
Filing Date:Mar 15, 2005
Application Number:11/080,130
Claims:1. A method of modifying a glycopeptide antibiotic to form a glycopeptide antibiotic derivative having reduced tissue accumulation when administered to a mammal, the method comprising forming a carboxy-saccharide derivative of the glycopeptide antibiotic that has a substituent comprising a dicarboxylic acid in which one of the carboxylic acid groups is coupled with a saccharide.

2. The method of claim 1, wherein the glycopeptide antibiotic is vancomycin or a derivative thereof.

3. The method of claim 1, wherein the glycopeptide antibiotic is chloroorienticin A or a derivative thereof.

4. The method of claim 1, wherein the glycopeptide antibiotic is teicoplanin or a derivative thereof.

5. The method of claim 1, wherein the substituent is a substituent of formula III: ##STR00012## wherein one of R.sup.g and R.sup.h is a saccharide, and the other of R.sup.g and R.sup.h is OH.

6. The method of claim 1, wherein the substituent is a substituent of formula IV: ##STR00013## wherein one of R.sup.m and R.sup.n is a saccharide, and the other is OH.

7. The method of claim 1, wherein the substituent is a substituent of formula (i): ##STR00014##

8. The method of claim 1, wherein the substituent is a substituent of formula (ii): ##STR00015##

9. The method of claim 1, wherein the substituent is a substituent of formula (iii): ##STR00016##

10. The method of claim 1, wherein the substituent is a substituent of formula (iv): ##STR00017##

11. A method of modifying a glycopeptide antibiotic to farm a glycopeptide antibiotic derivative having increased urinary clearance when administered to a mammal, the method comprising forming a carboxy-saccharide derivative of the glycopeptide antibiotic that has a substituent comprising a dicarboxylic acid in which one of the carboxylic acid groups is coupled with a saccharide.

12. The method of claim 11, wherein the glycopeptide antibiotic is vancomycin or a derivative thereof.

13. The method of claim 11, wherein the glycopeptide antibiotic is chloroorienticin A or a derivative thereof.

14. The method of claim 11, wherein the glycopeptide antibiotic is teicoplanin or a derivative thereof.

15. The method of claim 11, wherein the substituent is a substituent of formula III: ##STR00018## wherein one of R.sup.g and R.sup.h is a saccharide, and the other R.sup.g and R.sup.h is OH.

16. The method of claim 11, wherein the substituent is a substituent of formula IV: ##STR00019## wherein one of R.sup.m and R.sup.n is a saccharide, and the other is OH.

17. The method of claim 11, wherein the substituent is a substituent of formula (i): ##STR00020##

18. The method of claim 11, wherein the substituent is a substituent of formula (ii): ##STR00021##

19. The method of claim 11, wherein the substituent is a substituent of formula (iii): ##STR00022##

20. The method of claim 11, wherein the substituent is a substituent of formula (iv): ##STR00023##
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Chinese Patent Office
Julphar
Fuji
Argus Health
Fish and Richardson
Colorcon
Johnson and Johnson
Cantor Fitzgerald
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot